Outcome of Partial Splenectomy for Type I Gaucher Disease
Overview
Authors
Affiliations
Partial splenectomy was introduced to achieve the benefits of splenectomy and to avoid the risk of overwhelming infection in patients with symptomatic Gaucher disease. We observed regrowth of the splenic remnant, reemergence of preoperative symptoms, and new bone involvement among most of our patients who had undergone partial splenectomy. Enzyme replacement therapy has markedly limited indications for splenectomy, partial or total, for Gaucher disease.
Elstein D, Belmatoug N, Bembi B, Deegan P, Fernandez-Sasso D, Giraldo P J Clin Med. 2024; 13(12).
PMID: 38930117 PMC: 11204885. DOI: 10.3390/jcm13123588.
Review of the safety and efficacy of imiglucerase treatment of Gaucher disease.
Elstein D, Zimran A Biologics. 2009; 3:407-17.
PMID: 19774208 PMC: 2747339. DOI: 10.2147/btt.2009.3497.
Outcome of ten years' echocardiographic follow-up in children with Gaucher disease.
Rosengarten D, Abrahamov A, Nir A, Farber B, Glaser J, Zimran A Eur J Pediatr. 2006; 166(6):549-51.
PMID: 16941127 DOI: 10.1007/s00431-006-0276-z.
Gaucher disease: pediatric concerns.
Elstein D, Abrahamov A, Dweck A, Hadas-Halpern I, Zimran A Paediatr Drugs. 2002; 4(7):417-26.
PMID: 12083970 DOI: 10.2165/00128072-200204070-00001.
Enzyme replacement therapy for Gaucher's disease: the early Canadian experience.
Mackenzie J, Amato D, Clarke J CMAJ. 1998; 159(10):1273-8.
PMID: 9861225 PMC: 1229823.